Cyclica Inc. is awarded access to IBM's Blue Gene/Q supercomputer to repurpose FDA approved drugs

Cyclica Inc. is awarded access to IBM’s Blue Gene/Q supercomputer for large-scale repurposing project. Read the full press release

The Blue Gene/Q computing platform designed for massive parallel processing and grand challenge computational science to enable rapid prototyping and modeling. For more information on IBM’s Blue Gene/Q supercomputer, please visit the IBM solutions site:

For more information about SOSCIP, please visit: